1087243-34-2Relevant academic research and scientific papers
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies
Ghosh, Arun K.,Raghavaiah, Jakka,Shahabi, Dana,Yadav, Monika,Anson, Brandon J.,Lendy, Emma K.,Hattori, Shin-Ichiro,Higashi-Kuwata, Nobuyo,Mitsuya, Hiroaki,Mesecar, Andrew D.
, p. 14702 - 14714 (2021/10/01)
Here, we report the synthesis, structure-activity relationship studies, enzyme inhibition, antiviral activity, and X-ray crystallographic studies of 5-chloropyridinyl indole carboxylate derivatives as a potent class of SARS-CoV-2 chymotrypsin-like protease inhibitors. Compound 1 exhibited a SARS-CoV-2 3CLpro inhibitory IC50 value of 250 nM and an antiviral EC50 value of 2.8 μM in VeroE6 cells. Remdesivir, an RNA-dependent RNA polymerase inhibitor, showed an antiviral EC50 value of 1.2 μM in the same assay. Compound 1 showed comparable antiviral activity with remdesivir in immunocytochemistry assays. Compound 7d with an N-allyl derivative showed the most potent enzyme inhibitory IC50 value of 73 nM. To obtain molecular insight into the binding properties of these molecules, X-ray crystal structures of compounds 2, 7b, and 9d-bound to SARS-CoV 3CLpro were determined, and their binding properties were compared.
Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
Ghosh, Arun K.,Gong, Gangli,Grum-Tokars, Valerie,Mulhearn, Debbie C.,Baker, Susan C.,Coughlin, Melissa,Prabhakar, Bellur S.,Sleeman, Katrina,Johnson, Michael E.,Mesecar, Andrew D.
scheme or table, p. 5684 - 5688 (2009/05/30)
Design, synthesis and biological evaluation of a series of 5-chloropyridine ester-derived severe acute respiratory syndrome-coronavirus chymotrypsin-like protease inhibitors is described. Position of the carboxylate functionality is critical to potency. I
